Frequently Asked Questions
The market is segmented based on , By Product Type (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)), Mode of Administration (Oral, Parenteral), Source (Bovine, Porcine), Ingredients (Sodium, Calcium, Others), Availability (Raw, Processed), Treatment (Deep Vein Thrombosis, Pulmonary Embolism, Arterial Thromboembolism, Others), Application (Pre-Surgical Procedures, Post-Surgical Procedures, Kidney Dialysis, Diagnostic Tests, Others), Therapeutics (Cardiovascular, Respiratory, Oncology, Nephrology, CNS, Others), Strength (10 Unit, 100 Unit, 1000 Unit, 5000 Unit, 10000 Unit, 25000 Unit, Others), Type (Generics, Brands), Container (Bottles, Bags, Vials, Others), Packaging (Glass, Plastic), End User (Hospitals, Clinics, Homecare, Ambulatory Surgical Centres, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Drug Store, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.
.
The Europe Heparin Market size was valued at USD 3472.05 USD million in 2022.
The Europe Heparin Market is projected to grow at a CAGR of 5.83% during the forecast period of 2023 to 2030.
The market report covers data from the Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, Rest of Europe.
